You could use one of your burner phones
Coronavirus vaccine news
- Thread starter SirRumpole
- Start date
-
- Tags
- coronavirus covid-19 news vaccine
Government's “appalling” error, rejects offer of 40 million Pfizer doses in July 2020 - Michael West
Australia was given options for as many Pfizer doses as needed to be delivered in January, yet government officials turned down the offer
www.michaelwest.com.au
I actually don't think I need it either. In fact I think I had covid previously.
And if vaccination is a yearly thing, then I ain't likely to get it again.
My old man recently was vaccinated and seems fine.
Covid seems a bit overblown by the media to me.
I can't afford any downtime which is the only reason I'll get it. If everyone else were to get sick I have to look after them all. So for me it's just preparation for a worse case.
IFocus
You are arguing with a Galah
- Joined
- 8 September 2006
- Posts
- 7,472
- Reactions
- 4,467
I have had the 1st AZ and don't know what all the fuss is about, I think a good gauge as to its risk is the fact all our leading politicians have a an AZ jab too... oh hang on 
.
I can understand people waiting for Pfizer
.I can understand people waiting for Pfizer
Knobby22
Mmmmmm 2nd breakfast
- Joined
- 13 October 2004
- Posts
- 9,609
- Reactions
- 6,401
I can too understand people waiting for Pfizer too,but this Delta variant is likely to mean people may not get it in time, at least on the east coast.I have had the 1st AZ and don't know what all the fuss is about, I think a good gauge as to its risk is the fact all our leading politicians have a an AZ jab too... oh hang on
I can understand people waiting for Pfizer
I predict Sydney will be in lockdown by Tuesday.
Yeah I had a AZ jab a couple of weeks ago.....if I stop posting you will figure it outI have had the 1st AZ and don't know what all the fuss is about, I think a good gauge as to its risk is the fact all our leading politicians have a an AZ jab too... oh hang on
I can understand people waiting for Pfizer
I trust the Canadians more than that Greghunt
- Joined
- 3 July 2009
- Posts
- 27,047
- Reactions
- 23,587
My guess, is within a few weeks, the Pfizer vaccine will be an optional for all.
IFocus
You are arguing with a Galah
- Joined
- 8 September 2006
- Posts
- 7,472
- Reactions
- 4,467
Yes the east coast is a different situation I was speaking from the COVID utopia of WA
There was speculation as to whether NSW would able to run the hot spot thing with the new variants I think you will be right re Sydney I would be running to the nearest vaccine clinic if I was east coast.
Hope all stay safe regardless what ever course is chosen.
- Joined
- 3 July 2009
- Posts
- 27,047
- Reactions
- 23,587
Australian mRNA vaccine to be trailed.
www.abc.net.au
Australia's first local mRNA coronavirus vaccine trials will start 'within months'
Victoria's Acting Premier James Merlino announces $5 million of the government's $50 million pot of funds for battling coronavirus will be spent on a program at Monash University to produce mRNA vaccines.
www.abc.net.au
Knobby22
Mmmmmm 2nd breakfast
- Joined
- 13 October 2004
- Posts
- 9,609
- Reactions
- 6,401
Australia's medical regulator does not expect key data from the country's third major Covid 19 vaccine hopeful Novavax till September.
Knobby22
Mmmmmm 2nd breakfast
- Joined
- 13 October 2004
- Posts
- 9,609
- Reactions
- 6,401
Gladys targeting 40,000 tests a day.
If anyone can stop this without a lockdown it would be her. Truly impressive leader.
If anyone can stop this without a lockdown it would be her. Truly impressive leader.
- Joined
- 29 January 2006
- Posts
- 7,217
- Reactions
- 4,437
Below is an update on total numbers vaccinated, this time including several continents, plus high income countries.
Low income nations presently account for less than 1% of total vaccinations:
I suspect that what will happen over coming months is that more and more high income nations with relatively high vaccination rates will open up to each other. Africa as a continent with many borders shared across low income nations is unlikely to get a look in until late 2022 unless a massive effort is made to rectify this imbalance.
Low income nations presently account for less than 1% of total vaccinations:
I suspect that what will happen over coming months is that more and more high income nations with relatively high vaccination rates will open up to each other. Africa as a continent with many borders shared across low income nations is unlikely to get a look in until late 2022 unless a massive effort is made to rectify this imbalance.
- Joined
- 3 July 2009
- Posts
- 27,047
- Reactions
- 23,587
Interesting read on the new vaccine developments.
www.abc.net.au
From the article: a summary.
Firstly, we've learnt about the progress being made on the development of a potential mRNA vaccine here in Australia.
It's been developed by Monash University researchers, who are partnering with the Doherty Institute to run trials looking at both the mRNA and a protein vaccine at the same time.
They are hoping to have Phase 1 clinical trial up and running by October or November, with around 150 trial participants.
Existing vaccines have been modelled on the original version of the virus first detected in Wuhan.
Professor Pouton said the second key difference was that existing approved vaccines were what you might call "whole spike vaccines", which prompted the body to build antibodies for the whole spike of the virus.
"The problem with that is that you're sort of raising antibodies against other parts of the protein, which isn't necessarily a problem if the only vaccine is the only virus circulating is Wuhan [strain]," he said.
But variants that have emerged contain mutations at what's referred to as the "receptor-binding domain", which Professor Pouton said accounted for roughly 10 per cent of the overall mass of the coronavirus spike protein.
The new vaccine candidate is aimed at presenting solely the receptor-binding domain to the immune system.
"The advantage of that is that it should lead to neutralising antibodies which bind directly to the receptor-binding domain, which is what we're really trying to achieve with an antibody response," Professor Pouton said.
He said his team believed this approach was likely to produce a better kind of booster shot for future variants, which could be given to those already vaccinated against the original strain.
The team is also in the early stages of testing an mRNA vaccine candidate modelled on the Kappa variant.
How this mRNA vaccine being developed in Australia differs from Pfizer
Australia's first locally designed and manufactured COVID-19 mRNA vaccine could be within sight, with the first candidate due to start Phase 1 clinical trials by around October or November.
www.abc.net.au
So what's been announced?
There are two linked, but separate, parts to the announcement.Firstly, we've learnt about the progress being made on the development of a potential mRNA vaccine here in Australia.
It's been developed by Monash University researchers, who are partnering with the Doherty Institute to run trials looking at both the mRNA and a protein vaccine at the same time.
They are hoping to have Phase 1 clinical trial up and running by October or November, with around 150 trial participants.
How is this mRNA vaccine candidate different to Pfizer?
Professor Pouton said the vaccine under development was a "variant vaccine", modelled from the Beta strain, which was first detected in South Africa.Existing vaccines have been modelled on the original version of the virus first detected in Wuhan.
Professor Pouton said the second key difference was that existing approved vaccines were what you might call "whole spike vaccines", which prompted the body to build antibodies for the whole spike of the virus.
"The problem with that is that you're sort of raising antibodies against other parts of the protein, which isn't necessarily a problem if the only vaccine is the only virus circulating is Wuhan [strain]," he said.
But variants that have emerged contain mutations at what's referred to as the "receptor-binding domain", which Professor Pouton said accounted for roughly 10 per cent of the overall mass of the coronavirus spike protein.
The new vaccine candidate is aimed at presenting solely the receptor-binding domain to the immune system.
"The advantage of that is that it should lead to neutralising antibodies which bind directly to the receptor-binding domain, which is what we're really trying to achieve with an antibody response," Professor Pouton said.
He said his team believed this approach was likely to produce a better kind of booster shot for future variants, which could be given to those already vaccinated against the original strain.
The team is also in the early stages of testing an mRNA vaccine candidate modelled on the Kappa variant.
Knobby22
Mmmmmm 2nd breakfast
- Joined
- 13 October 2004
- Posts
- 9,609
- Reactions
- 6,401
Don't forget I predicted lockdown Tuesday (today)! Let's see.
If she doesn't she will be a mug.
Info from Public Health England, the Govt website, data is from February 1st to June 7th 2021
Of 33,206 Delta variant cases admitted to the hospital, 19,573 were not vaccinated. Of those, 23 (or 0.1175%) died.
Of the 1,785 patients who had both vaccine doses 14 days or more before admission, 12 (or 0.6722%) died. This death rate is 5.72 times higher than that for unvaccinated patients.
Even after you have been vaccinated you still need to be careful
Of 33,206 Delta variant cases admitted to the hospital, 19,573 were not vaccinated. Of those, 23 (or 0.1175%) died.
Of the 1,785 patients who had both vaccine doses 14 days or more before admission, 12 (or 0.6722%) died. This death rate is 5.72 times higher than that for unvaccinated patients.
Even after you have been vaccinated you still need to be careful
- Joined
- 3 July 2009
- Posts
- 27,047
- Reactions
- 23,587
Pfizer for all after October.
www.smh.com.au
From the article:
Australia will likely not use the AstraZeneca vaccine after October except by request, with the national rollout to rely on Pfizer doses to immunise the nation against the coronavirus.
AstraZeneca vaccine to be used from October only on request
The national rollout will rely on millions of doses of Pfizer to immunise the population against COVID-19, with most over-60s expected to be vaccinated before October.
Australia will likely not use the AstraZeneca vaccine after October except by request, with the national rollout to rely on Pfizer doses to immunise the nation against the coronavirus.
Oxford University explores anti-parasitic drug ivermectin as COVID-19 treatment
The University of Oxford said on Wednesday it was testing anti-parasitic drug ivermectin as a possible treatment for COVID-19, as part of a British government-backed study that aims to aid recoveries in non-hospital settings.
